-
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus’ Post Grant Review
27 Mar 2024 12:57 GMT
… (RSE). Marinus has multiple patents relating to ganaxolone for the … will vigorously defend our patents which support our mission … treatment of SE. These patents cover the clinical dosing … for patients with rare genetic epilepsies and refractory seizure …
-
Bicycle Therapeutics files patent for method for determining cyclisation extent of peptide ligand
26 Mar 2024 15:58 GMT
… innovation area identified from patents. Bicycle Therapeutics… to total number of patents.
Method for determining … peptide ligands displayed on genetic systems, with potential … forward citations from global patenting offices. Textual analysis and …
-
DNA Synthesizer Market Set to Reach USD 677.1 Million by 2030, Fueled by Advancements in Genetic Research
25 Mar 2024 14:38 GMT
The increasing demand for synthetic biology applications are driving the exponential growth of the DNA Synthesizer Market.
AUSTIN, TEXAS, UNITED STATES, March 25, 2024 /EINPresswire.com/ -- The DNA Synthesizer Market has seen substantial growth …
-
CSL gets grant for method of reducing GVHD risk in hct patients with a1at
29 Mar 2024 15:05 GMT
… grants to total number of patents.
A recently granted patent … leukemia, lymphoma, myeloma, and genetic hematopoietic disorders. The patent … forward citations from global patenting offices. Textual analysis and … are used to group patents into key thematic areas …
-
Tiny Organisms, Transformative Outcomes
29 Mar 2024 14:06 GMT
… can present different advantages for genetic engineers like himself.
Crook, an … State alum – use Crook’s patented techniques to deliver its methane …
-
Today-History-Apr13
29 Mar 2024 14:45 GMT
… 1869, American industrialist George Westinghouse patented the air brake.
In 1900 … announced they had identified the genetic code of the virus suspected …
-
Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series
29 Mar 2024 06:30 GMT
Introduction
Biliary tract cancer (BTC) refers to several cancers of the biliary system, and covers a range of invasive adenocarcinomas, including intrahepatic cholangiocarcinoma (iCCA), extrahepatic cholangiocarcinoma, gallbladder carcinoma, and ampullary …
-
Scientists Warn Against Liberalising Rules on Genetic Engineering
… no financial interest in GE patents or IP. Public conversation and … on the risks of new genetic engineering from the perspective of … ;en/news/new-genetic-engineering-scientists-oppose-eu-commission …
-
USF study: Genomic research may help explain cancer resistance in Tasmanian devils
28 Mar 2024 22:25 GMT
… question in biology is the genetic basis for disease. The classic … the world for securing new patents, USF is a leader in …
-
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
28 Mar 2024 20:30 GMT
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, …